Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
68.50    -2.00 (-2.84%)
Bid:
68.00
Ask:
69.00
Spread: 1.00 (1.471%)
Market Cap: £320.96m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Issue of Equity

20 Jan 2014 07:00

RNS Number : 0026Y
Avacta Group PLC
20 January 2014
 



 

 

 

 

 

Avacta Group plc

("Avacta" or the "Group")

 

Issue of Equity

 

Avacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, today announces that 3,529,411 Ordinary Shares of 0.1p ("new Ordinary Shares") have been issued by the Company pursuant to the exercise of share options by an employee.

 

Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 24 January 2014.

 

The total number of Ordinary Shares in issue following the above issue will be 4,022,551,956 each with voting rights. No Ordinary Shares are held in Treasury.

 

The above figure of 4,022,551,956 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

 

 

- Ends -

 

Enquiries:

Avacta Group plc

Tel: +44 (0) 844 414 0452

Alastair Smith, Chief Executive Officer

www.avacta.com

Tim Sykes, Chief Financial Officer

Numis Securities Limited

Tel: +44 (0) 207 260 1000

Michael Meade / Freddie Barnfield - Nominated Adviser

www.numiscorp.com

James Black - Corporate Broking

Walbrook PR Ltd

Tel: +44 (0) 20 7933 8780 or avacta@walbrookpr.com

Paul McManus

Mob: +44 (0)7890 541 893

Lianne Cawthorne

Mob: +44 (0)7584 391 303

 

 

 

 

 

 

 

 

 

 

 

 

About Avacta Group plc - www.avacta.com

 

Avacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:

 

Avacta Analytical

www.avactaanalytical.com

 

High throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.

Avacta Animal Health

www.avactaanimalhealth.com

 

Veterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.

Avacta Life Sciences

www.avactalifesciences.com

 

Novel non-antibody affinity reagents called Affimers, with a wide range of Life Science applications in diagnostics, drug and biomarker discover and biotech research and development.

 

Avacta joined AIM in August 2006 and is based in Wetherby, England.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUWVNRSOAAAAR
Date   Source Headline
5th Oct 20117:00 amRNSSouth East Asian Alliance agreed with Pall
19th Sep 20117:00 amRNSNotice of Preliminary Results
9th Aug 20117:00 amRNSPre-close Trading Update
6th Jul 20117:00 amRNSChange of Registered Office
10th Jun 201112:50 pmRNSDirector/PDMR Shareholding
31st May 20117:00 amRNSAvacta secures second Optim sale in US
18th Apr 20117:00 amRNSInterim Results
12th Apr 201112:42 pmRNSIssue of Equity
29th Mar 20117:00 amRNSExclusive distribution agreement with DKSH Japan
28th Mar 20117:00 amRNSAdditional Listing
22nd Mar 201110:11 amRNSAdditional Listing
17th Mar 20117:00 amRNSDirectorate Change
4th Mar 20117:00 amRNSTrading Statement
23rd Feb 20117:00 amRNSRe Agreement
3rd Feb 20117:00 amRNSRe Agreement
3rd Feb 20117:00 amRNSIssue of Equity
27th Jan 20114:55 pmRNSHolding(s) in Company
27th Jan 20117:00 amRNSDirector/PDMR Shareholding
26th Jan 20117:00 amRNSIssue of Equity
25th Jan 201111:57 amRNSHolding(s) in Company
21st Jan 20113:47 pmRNSAGM Result and Placing
12th Jan 20117:00 amPRNPlacing, Issue of Equity and related party transaction
5th Jan 201111:59 amPRNExercise of Warrants
4th Jan 20116:28 pmPRNHolding(s) in Company
4th Jan 20117:00 amRNSProduct Sale
31st Dec 20109:57 amPRNHolding(s) in Company
30th Dec 20102:36 pmPRNHolding(s) in Company
25th Nov 20107:00 amRNSProduct Launch
15th Nov 20107:00 amPRNGrant of Options to Directors
3rd Nov 20107:00 amRNSFinal Results
27th Oct 20107:00 amRNSProduct Sale
27th Oct 20107:00 amRNSProduct Sale
26th Oct 20107:00 amPRNIssue of Equity
14th Oct 20107:00 amRNSRe Agreement
20th Sep 20107:00 amPRNLicensing Agreement
7th Sep 20105:08 pmPRNHolding(s) in Company
6th Sep 20107:00 amPRNDistribution Agreement
6th Aug 20109:55 amPRNDirector/PDMR Shareholding
29th Jul 20107:00 amPRNIssue of Equity
6th Jul 20107:00 amPRNIssue of Equity
1st Jun 20107:00 amPRNChange of Adviser
30th Apr 20107:00 amPRNHalf-yearly Report
8th Mar 20107:00 amRNSNotice of Results and Trading Update
3rd Mar 20107:00 amRNSAcquisition
22nd Feb 20102:42 pmRNSDirector/PDMR Shareholding
25th Jan 20107:00 amRNSResult of AGM
21st Dec 200910:35 amRNSIssue of Equity
26th Nov 20097:03 amRNSPreliminary Results
26th Nov 20097:00 amRNSIssue of Equity
4th Nov 20097:00 amPRNNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.